NSE:APLLTD 09.09.2024 Buy-1203 Target 1- 1282 Target 2-1575 Stop Loss- 1020 Risk Reward- 1:2 Holding period- 3 to 6 Months Very good fundamentals along with below technical analysis 1.Inside bar breakout in weekly TF 2.Trend- Continues uptrend from last one year 3.Price has taken retracement at very strong key level 4.Gradual increase in volumes. 5. Very...
Indices are far more reliable during technical analysis as compared to the individual stocks. The pattern is a clean one in Nifty Pharma Index. This is to spread the awareness about technical chart patterns and not a buy/sell recommendation. Always do your own research before making any financial decision.
Company Overview: Sanofi NASDAQ:SNY is a major pharmaceutical company based in Paris, with a market capitalization of $134 billion. Investment Highlights: Dividend Yield: 3.8%, more than double the S&P 500 average. Drug Portfolio: Diverse and includes successful drug developments. Pipeline: Promising future drug pipeline with potential for growth. Berkshire...
Eli Lilly and Company (LLY) posted a miraculous bullish reversal in the past 2 weeks, recovering yesterday all of the losses of the brutal correction since its July 15 All Time High. Having rebounded on its 1D MA200 (orange trend-line) while the 1D RSI touched the 30.00 oversold barrier for the first time since February 28 2023, we can claim that LLY's Channel Up...
Axsome - NASDAQ:AXSM ✅In position since Feb 2023 with average price $50.00 per share. This is a long term 3 - 5 year hold. ✅ Current unrealized gain at 75% ✅ Stop Loss set at $63.80 for 50% of the position to ensure short term gain capture ⏳We awaiting increasing levels of volume (see the green zone). Volume moving into this zone would be ideal and...
The chart presented here is a daily chart, detailing precise entry and stop-loss levels. However, upon examining the weekly chart, a breakout of the cup pattern becomes evident. The target for this pattern is determined by the depth of the cup, making it a compelling long-side investment. The projected target is approximately 700 points higher, suggesting that the...
GlaxoSmithKline Pharmaceuticals , a major player in the pharmaceutical industry, is displaying technical signals that suggest a potential swing trade opportunity. Reasons are listed below : Breakthrough of Strong Resistance (1800-1900) : The 1800-1900 range was a significant resistance level. The price has broken through, retested, and is now making new highs,...
This chart is very interesting as well as confusing at the same time for some people let's break it down step by step. If you see the monthly chart of Natco Pharma you will notice many patterns there like:- Cup pattern W pattern Pole and flag Pattern Volume is increasing significantly on the monthly chart Breakout already happened last week but...
Does anyone else see a massive cup and handle here?
For the past few weeks we have been trying to understand how to use the performance of an index reflects in performance of stocks that are constituents of that particular index and vice versa. By catching the index that is on the verge of breaking out or has broken out during the week, we can plan our investment and trades around it to maximize our returns. We...
DISCLOSURE: as of 6/26 I have no open position in SIX:RO Roche is a Swiss based pharmaceutical conglomerate with a diverse range of operations and brands. The company has a long history of profitability and high returns on investment. Management Effectiveness: Roche has been around since 1896 and has had consistent growth over the economic cycles. Return on...
It's no secret the elite are manufacturing pandemics to herd, destroy and remake society into a neofeudal system controlled by social credit scores. The next pandemic will be H1N1 which has already been shared within the news that milk in the markets has trace amounts of (no worry they say!). After the establishment rolls out bird-flu for everyone's summer bingo...
#PHA The price is moving in a bearish channel pattern on the 4-hour frame, and it adheres to it well, and it is expected to break to the upside The price rebounded well from the lower border of the channel at the green support level 0.1650, which is a strong level. We have a tendency to stabilize above the Moving Average 100 We have oversold resistance on the RSI...
SUPPLY ZONE & 5 MONTHS BREAKOUT Breakout point - 150 ENTRY - 150 SL - 137 TARGETS - 165, 180 Disclaimer - All information on this page is for educational purposes only, we are not SEBI Registered, Please consult a SEBI registered financial advisor for your financial matters before investing And taking any decision. We are not responsible for any profit/loss you made.
Symmetrical Triangle was a a text book trade. The previous trend was up. Price broke above the apex 3/4s in and the momentum continued up. We had further indicators of confirmation for upside to come. Price>20 Price>200 Target 1 R206.03 So what now? Well we can expect somewhat a consolidation, and a potential Cup and Handle to form. Then we have the next target...
Amylyx stock ( NASDAQ:AMLX ) crashed Friday, losing almost all of its value, after the company said its approved ALS treatment, Relyvrio, failed in a pivotal study. Patients who received Amylyx Pharmaceuticals' ( NASDAQ:AMLX ) Relyvrio showed no significant difference across multiple markers measuring the severity of amyotrophic lateral sclerosis, the longhand...
In a quest to reclaim lost ground and assert its presence in the competitive COVID-19 vaccine market, Novavax (NASDAQ: NASDAQ:NVAX ) charts a strategic course aimed at improving commercial performance and gaining market share from industry giants Pfizer (PFE.N) and Moderna (MRNA.O). Despite facing headwinds and a larger-than-expected fourth-quarter loss, Novavax...
The biggest pharma giants are easy to recognize. Johnson and Johnson, Pfizer, Moderna, Merck & Co, Danaher Corp, Thermo Fisher Scientific. All medications and pharmaceutical drugs come out of these drug corporations. Lab equipment, medical research, vaccines, and other life science developments come out of these conglomerate pharma giants. Support and Resistance...